Natural compounds targeting noncanonical Inflammasomes: Molecular mechanisms and pharmacological potential.
文献摘要
The noncanonical inflammasomes, mediated by murine caspase-11 and its human orthologues caspase-4 and caspase-5, are central components of innate immunity that detect cytosolic lipopolysaccharide (LPS) and initiate gasdermin D (GSDMD)-dependent pyroptosis and inflammatory responses. Although indispensable for host defense against Gram-negative bacterial infection, dysregulated activation of this pathway contributes to the pathogenesis of a broad spectrum of inflammatory diseases, highlighting the noncanonical inflammasomes as attractive therapeutic targets. Increasing evidence indicates that natural compounds modulate noncanonical inflammasome signaling; however, their mechanisms of action and translational potential have not been comprehensively evaluated. Here, we provide a comprehensive overview of the molecular mechanisms governing noncanonical inflammasome activation and of natural compounds, including phenolic compounds, terpenoids, alkaloids, and polysaccharides, that target this pathway. These compounds suppress noncanonical inflammasome signaling through diverse yet convergent mechanisms, including inhibition of cytosolic LPS sensing, modulation of upstream regulatory pathways, suppression of caspase-4/11 noncanonical inflammasome activation, attenuation of GSDMD-mediated pyroptosis, and regulation of oxidative stress and cellular homeostasis. These mechanisms confer protection against diverse experimental inflammatory diseases, supporting the therapeutic potential of natural compounds for the prevention and treatment of noncanonical inflammasome-driven human disorders. We further discuss current challenges, including limited validation in human caspase-4/5 systems, unresolved molecular targets, and translational barriers, and highlight future research directions to facilitate the development of mechanism-based therapeutics targeting the noncanonical inflammasomes.